Home » Posts tagged with » Cosela
G1 Therapeutics gets Cosela FDA approval to reduce chemotherapy-induced bone marrow suppression
G1 Therapeutics has bagged approval for Cosela (trilaciclib) from the US Food and Drug Administration (FDA) for reducing bone marrow suppression caused by chemotherapy. Cosela FDA approval is for its use in cutting down the frequency of chemotherapy-induced bone marrow suppression in adults who are undergoing certain types of chemotherapy for extensive-stage small cell lung […]
Business News Today
- Önusberget wind farm : GE Renewable Energy bags contract for 137 turbines
- El Campo project : Ely Gold Royalties acquires heavy rare earth project in California
- NER-II transmission project : IndiGrid to acquire NER-II from Sterlite Power for $630m
- Wipro to acquire management and technology consultancy Capco for $1.4bn
- Dabur India launches Dabur Vatika Select shampoo range
- KKR to acquire majority stake in Integrated Specialty Coverages
- Amgen to acquire Five Prime Therapeutics for gastric cancer candidate bemarituzumab
- Adani Ports to acquire stake in Gangavaram Port for $270m
- Infosys to create 500 new jobs in Calgary amid Canadian expansion
- Boston Scientific to acquire Lumenis surgical business for $1bn